Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Escobar

Showing results (21-30 of 368) with videos related to

Pageof 37
Sort By:
Revista Espanola De Cardiologia (English Ed.)|April 30, 2014
Does CHA₂DS₂-VASc score select patients who will benefit most from anticoagulation? ResponseVivencio Barrios, Carlos Escobar
Revista Espanola De Cardiologia (English Ed.)|April 30, 2014
Use of antithrombotic therapy in patients with atrial fibrillation in primary care. Importance of INR control. ResponseCarlos Escobar, Vivencio Barrios
Expert Opinion on Pharmacotherapy|December 14, 2007
Olmesartan medoxomil plus hydrochlorothiazide for treating hypertensionVivencio Barrios, Carlos Escobar
Cardiovascular & Hematological Agents in Medicinal Chemistry|October 26, 2012
Rosuvastatin and diabetes: when the evidences talkVivencio Barrios, Carlos Escobar
The Lancet. Oncology|September 7, 2010
Angiotensin-receptor blockade, cancer, and concernsVivencio Barrios, Carlos Escobar
Expert Review of Cardiovascular Therapy|November 25, 2010
Valsartan-amlodipine-hydrochlorothiazide: the definitive fixed combination?Vivencio Barrios, Carlos Escobar
Expert Review of Cardiovascular Therapy|November 27, 2010
Antihypertensive and organ-protective effects of benazeprilVivencio Barrios, Carlos Escobar
Integrated Blood Pressure Control|August 28, 2014
Which thiazide to choose as add-on therapy for hypertension?Vivencio Barrios, Carlos Escobar
European Journal of Heart Failure|March 13, 2019
Mineralocorticoid receptor antagonists and acute heart failureCarlos Escobar, Luis Manzano
Expert Opinion on Drug Metabolism & Toxicology|April 9, 2013
An evaluation of the latest evidence relating to renin-angiotensin system inhibitorsCarlos Escobar, Vivencio Barrios
Pageof 37

Showing results (21-30 of 368) with videos related to

Sort By:
Pageof 37
Revista Espanola De Cardiologia (English Ed.)|April 30, 2014
Does CHA₂DS₂-VASc score select patients who will benefit most from anticoagulation? ResponseVivencio Barrios, Carlos Escobar
Revista Espanola De Cardiologia (English Ed.)|April 30, 2014
Use of antithrombotic therapy in patients with atrial fibrillation in primary care. Importance of INR control. ResponseCarlos Escobar, Vivencio Barrios
Expert Opinion on Pharmacotherapy|December 14, 2007
Olmesartan medoxomil plus hydrochlorothiazide for treating hypertensionVivencio Barrios, Carlos Escobar
Cardiovascular & Hematological Agents in Medicinal Chemistry|October 26, 2012
Rosuvastatin and diabetes: when the evidences talkVivencio Barrios, Carlos Escobar
The Lancet. Oncology|September 7, 2010
Angiotensin-receptor blockade, cancer, and concernsVivencio Barrios, Carlos Escobar
Expert Review of Cardiovascular Therapy|November 25, 2010
Valsartan-amlodipine-hydrochlorothiazide: the definitive fixed combination?Vivencio Barrios, Carlos Escobar
Expert Review of Cardiovascular Therapy|November 27, 2010
Antihypertensive and organ-protective effects of benazeprilVivencio Barrios, Carlos Escobar
Integrated Blood Pressure Control|August 28, 2014
Which thiazide to choose as add-on therapy for hypertension?Vivencio Barrios, Carlos Escobar
European Journal of Heart Failure|March 13, 2019
Mineralocorticoid receptor antagonists and acute heart failureCarlos Escobar, Luis Manzano
Expert Opinion on Drug Metabolism & Toxicology|April 9, 2013
An evaluation of the latest evidence relating to renin-angiotensin system inhibitorsCarlos Escobar, Vivencio Barrios
Pageof 37